Gyermekkori daganatok: vizsgálatok itt: Dél-Korea

In Dél-Korea 64 Also abroad 2481

64 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

1/2. fázisTaking people
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Where
Seoul
People
64 worldwide
Run by
RayzeBio, Inc.
See details and how to joinNCT06590857
1/2. fázisTaking people
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Where
Seoul
Életkor
1 év to 30 év
People
50 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07387926
2. fázisTaking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Jongno-gu, Songpa-gu
Életkor
12 év and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
3. fázisTaking people
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Where
Daegu, Goyang-si, Gyeonggi-do, Seoul
Életkor
15 év and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00
2. fázisTaking people
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Where
Seoul
Életkor
1 év to 18 év
People
50 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07354074
2. fázisTaking people
A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
Where
Seoul
Életkor
12 év to 17 év
People
15 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07700758 · EU 2025-524515-37-00
4. fázisTaking people
Asciminib Roll-over Study
Where
Busan, Jeollanam, Seoul, Uijeongbu-si
Életkor
7 év to 100 év
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
1/2. fázisTaking people
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Where
Goyang-si, Seoul
Életkor
12 év and over
People
840 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00
3. fázisTaking people
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Where
Goyang-si, Gyeonggi-do, Seongnam-si, Seoul
People
200 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00
1/2. fázisTaking people
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Where
Seoul
Életkor
6 hónap to 30 év
People
65 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT05533775
1/2. fázisTaking people
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Where
Seoul
Életkor
2 év and over
People
420 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00
2/3. fázisTaking people
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Where
Seoul
People
1541 worldwide
Run by
Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00
No phaseTaking people
Development and Utilization of an Integrated Clinical Genomic Database
Where
Seoul
People
118 750
Run by
Samsung Medical Center
See details and how to joinNCT07911267
1/2. fázisTaking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Seoul
Életkor
6 hónap to 25 év
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
1/2. fázisTaking people
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Where
Seoul
Életkor
1 hónap to 17 év
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07630974 · EU 2025-522339-32-00
1/2. fázisTaking people
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Where
Seoul
Életkor
16 év and over
People
85 worldwide
Run by
AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00
No phaseTaking people
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
Where
Daejeon, Goyang-si, Hwasun Gun, Seoul, Suwon, Uijeongbu-si, Yangsan
People
377
Run by
Astellas Pharma Korea, Inc.
See details and how to joinNCT06902545
3. fázisTaking people
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Where
Busan, Daegu, Goyang-si, Seoul
Életkor
12 év and over
People
468 worldwide
Run by
Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00
No phaseTaking people
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Where
Busan, Daegu, Daejeon, Goyang-si, Incheon, Jeollanam-do, Jeonju, Seoul, Suwon
People
228
Run by
Astellas Pharma Korea, Inc.
See details and how to joinNCT06011954
No phaseTaking people
Treatment Patterns and Survival Outcomes in High-Grade Osteosarcoma: A Multicenter Retrospective Study
Where
Goyang-si, Seoul
Életkor
12 év and over
People
400
Run by
MedPacto, Inc.
See details and how to joinNCT07878364
1/2. fázisTaking people
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Where
Seoul
Életkor
12 év and over
People
83 worldwide
Run by
AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00
2. fázisTaking people
ONO-4538 Phase II Rollover Study (ONO-4538-98)
Where
Daegu, Gyeonggi-do, Hwasun, Incheon, Seoul, Suwon
Életkor
16 év and over
People
70 worldwide
Run by
Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT04566380
1/2. fázisTaking people
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Where
Seoul
Életkor
12 év and over
People
255 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00
1/2. fázisTaking people
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Where
Seoul
Életkor
12 év and over
People
161 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00
No phaseTaking people
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
Where
Seoul
People
2000
Run by
Samsung Medical Center
See details and how to joinNCT07032103